SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036997
Filing Date
2020-08-06
Accepted
2020-08-05 18:00:56
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20200630.htm   iXBRL 10-Q 3342364
2 EX-31.1 stro-ex311_8.htm EX-31.1 17665
3 EX-31.2 stro-ex312_9.htm EX-31.2 16897
4 EX-32.1 stro-ex321_7.htm EX-32.1 6607
5 EX-32.2 stro-ex322_6.htm EX-32.2 6637
  Complete submission text file 0001564590-20-036997.txt   10972669

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stro-20200630.xsd EX-101.SCH 74043
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20200630_cal.xml EX-101.CAL 39839
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20200630_def.xml EX-101.DEF 285502
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20200630_lab.xml EX-101.LAB 543187
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20200630_pre.xml EX-101.PRE 423288
11 EXTRACTED XBRL INSTANCE DOCUMENT stro-10q_20200630_htm.xml XML 2090549
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 201078904
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences